Galleon names Brookes senior VP
Thursday, December 1, 2011
Galleon Pharmaceuticals has named Lynne M. Brookes senior vice president and chief business officer.
Brookes joins Galleon from Cephalon where she held a variety of product management, marketing and business development positions and was most recently vice president of business development.
“Lynne is uniquely well-qualified to serve as our chief business officer because of her experience launching and managing very successful pharmaceutical products in markets that include many breathing-control-disorder patients. She provides a strong commercial perspective to complement our established drug-discovery and clinical-development teams,” said James C. Mannion, Ph.D., Galleon’s president, chief executive officer and founder.